On 2025-05-08, Pliant Therapeutics, Inc. (PLRX) announced earnings per share of $-0.92 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.73.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.62 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.73 | $-0.92 |
| 2025-03-03 | 2024-12-31 | $-0.99 | $-0.82 |
| 2024-11-07 | 2024-09-30 | $-0.99 | $-0.95 |
| 2024-08-07 | 2024-06-30 | $-0.85 | $-0.92 |
| 2024-05-06 | 2024-03-31 | $-0.76 | $-0.78 |
| 2024-02-27 | 2023-12-31 | -- | $-0.69 |
| 2023-11-09 | 2023-09-30 | $-0.78 | $-0.70 |
| 2023-08-09 | 2023-06-30 | $-0.73 | $-0.70 |
| 2023-05-09 | 2023-03-31 | $-0.66 | $-0.67 |
| 2023-03-09 | 2022-12-31 | $-0.70 | $-0.72 |
| 2022-11-08 | 2022-09-30 | $-0.74 | $-0.65 |
| 2022-08-08 | 2022-06-30 | $-0.82 | $-0.82 |
| 2022-05-09 | 2022-03-31 | $-0.77 | $-0.78 |
| 2022-02-28 | 2021-12-31 | $-0.76 | $-0.68 |
| 2021-11-09 | 2021-09-30 | $-0.71 | $-0.75 |
| 2021-08-09 | 2021-06-30 | $-0.64 | $-0.64 |
| 2021-05-10 | 2021-03-31 | $-0.59 | $-0.64 |
| 2021-03-16 | 2020-12-31 | -- | $-0.54 |
| 2020-11-10 | 2020-09-30 | $-1.10 | $-0.47 |
| 2020-08-11 | 2020-06-30 | $-0.79 | $-1.39 |